Literature DB >> 23900471

Relationship between thyroid-stimulating hormone and blood pressure in the middle-aged and elderly population.

Wei-Xia Jian1, Jie Jin, Li Qin, Wen-Jun Fang, Xue-Ru Chen, Han-Bei Chen, Qing Su, Hui-Li Xing.   

Abstract

INTRODUCTION: Hypothyroidism and subclinical hypothyroidism may be associated with hypertension and metabolic syndrome. The aim of this study was to investigate the relationship between thyroid-stimulating hormone (TSH) and blood pressure, as well as the relationship between thyroid function and insulin resistance in middle-aged and elderly Chinese.
METHODS: This was a cross-sectional, community-based study. Serum TSH, fasting glucose and insulin were measured in 2,988 subjects aged 35-80 years. Logistic regression analysis was used to identify the risk factors for hypertension. Analysis of variance and multiple linear regression analysis were performed to characterise the relationship among TSH, insulin resistance and blood pressure.
RESULTS: Higher serum TSH concentration was found to be an independent risk factor for hypertension in females (odds ratio 1.4, 95% confidence interval 1.02-1.93; p-value = 0.039). The female group with subclinical hypothyroidism and high normal TSH (2.5-4.8 mIU/L) were more susceptible to high blood pressure than those with low normal TSH (0.3-2.5 mIU/L) (p-value < 0.05). After adjustment for waist-hip ratio and body mass index, neither the correlation between blood pressure and homeostasis model assessment of insulin resistance (HOMA-IR) nor the correlation between TSH and HOMA-IR were found to be significant in this study.
CONCLUSION: This study provides evidence that both subclinical hypothyroidism and high normal TSH are independent risk factors for hypertension in middle-aged and elderly Chinese women.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23900471     DOI: 10.11622/smedj.2013142

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  6 in total

1.  In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia.

Authors:  Elisabetta Morini; Antonino Catalano; Antonino Lasco; Nunziata Morabito; Salvatore Benvenga
Journal:  Endocrine       Date:  2019-03-27       Impact factor: 3.633

2.  L-thyroxine malabsorption due to calcium carbonate impairs blood pressure, total cholesterolemia, and fasting glycemia.

Authors:  Elisabetta Morini; Antonino Catalano; Antonino Lasco; Nunziata Morabito; Salvatore Benvenga
Journal:  Endocrine       Date:  2018-10-27       Impact factor: 3.633

3.  Mining Chemical Activity Status from High-Throughput Screening Assays.

Authors:  Othman Soufan; Wail Ba-alawi; Moataz Afeef; Magbubah Essack; Valentin Rodionov; Panos Kalnis; Vladimir B Bajic
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

4.  Association Between Blood Pressure, Glomerular Filtration Rate, and Serum Thyroid-Stimulating Hormone Levels in Hypothyroid Patients: A Retrospective Single-Center Study.

Authors:  Manal O Alsulami; Nada M Alharbi; Dania W Alsulami; Sahar J Almaghrabi; Hadeel A Albaradei; Amani M Alhozali
Journal:  Cureus       Date:  2022-09-02

5.  Gender-Specific Differences on the Association of Hypertension with Subclinical Thyroid Dysfunction.

Authors:  Jingkai Zhang; Chao Huang; Zhaowei Meng; Yaguang Fan; Qing Yang; Wenjuan Zhang; Yuxia Gao; Zhenwen Yang; Heng Cai; Bo Bian; Yongle Li; Xuefang Yu; Xin Du; Shaopeng Xu; Jing Nie; Ming Liu; Jinhong Sun; Qing Zhang; Ying Gao; Kun Song; Xing Wang; Li Zhao
Journal:  Int J Endocrinol       Date:  2019-12-30       Impact factor: 3.257

6.  Association of thyroid hormones with blood pressure and arterial stiffness in the general population: The Dali study.

Authors:  Md Tasneem Jamal; Qing-Lu Li; Qi-Yan Li; Wan-Ying Liang; Li-Hong Wang; Jian-Hang Wei; Quan Liang; Nai-Qing Hu; Li-Hua Li
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-12-27       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.